Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 12, 2012, Pages 1155-1161

  Shin, Soojeong ^a   Lee, Ji Eun ^a   Hong, Jin Yong ^a   Sunwoo, Mun Kyung ^a   Sohn, Young Ho ^a   Lee, Phil Hyu ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; ORBITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA INNOMINATA; TEMPORAL CORTEX; THALAMUS; VISUAL HALLUCINATION; VISUAL MEMORY; VOXEL BASED MORPHOMETRY;

EID: 84869239825     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303391     Document Type: Article

References (40)

1. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-45. (Pubitemid 30162723)
2. Diederich NJ, Fenelon G, Stebbins G, et al. Hallucinations in Parkinson disease. Nat Rev Neurol 2009;5:331-42.
3. Grossi D, Trojano L, Pellecchia MT, et al. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. Int J Geriatr Psychiatry 2005;20:668-73. (Pubitemid 41131778)
4. Ramirez-Ruiz B, Junque C, Marti MJ, et al. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Mov Disord 2006;21:1483-7. (Pubitemid 44613306)
5. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. Mov Disord 2010;25:615-22.
6. Santangelo G, Trojano L, Vitale C, et al. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov Disord 2007;22:2418-25. (Pubitemid 351155990)
7. Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004;63:1409-16. (Pubitemid 39426273)
8. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study. Mov Disord 2008;23:2335-43.
9. Meppelink AM, de Jong BM, Renken R, et al. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009;132:2980-93.
10. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, et al. Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 2010;81:650-7.
11. Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007;14:750-6. (Pubitemid 47012171)
12. Meppelink AM, de Jong BM, Teune LK, et al. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations. Mov Disord 2011;26:142-7.
13. Ballanger B, Strafella AP, van Eimeren T, et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 2010;67:416-21.
14. Manganelli F, Vitale C, Santangelo G, et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Brain 2009;132:2350-5.
15. Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov Disord 2011;26:2496-503.
16. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
17. Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005;28:737-57; discussion 757-94.
18. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14. (Pubitemid 24382728)
19. Song SK, Lee JE, Park HJ, et al. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 2011;26:289-96.
20. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain RESEARCH & Consulting Co, 2003.
21. Kim H, Na DL. Normative data on the Korean version of the Boston naming test. J Clin Exp Neuropsychol 1999;21:127-33. (Pubitemid 29332001)
22. Cormack F, Aarsland D, Ballard C, et al. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2004;19:371-7. (Pubitemid 38461077)
23. Cho H, Yang DW, Shon YM, et al. Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J Korean Med Sci 2008;23:477-83.
24. Lee PH, Yeo SH, Yong SW, et al. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2007;78:1250-2.
25. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-707; quiz 1837.
26. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113. (Pubitemid 47440133)
27. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200. (Pubitemid 32843166)
28. George S, Mufson EJ, Leurgans S, et al. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol Aging 2011;32:1756-64.
29. Choi SH, Jung TM, Lee JE, et al. Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status. Neurobiol Aging 2012;33:1265-72.
30. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125:391-403. (Pubitemid 34127441)
31. Yamamoto R, Iseki E, Murayama N, et al. Correlation in Lewy pathology between the claustrum and visual areas in brains of dementia with Lewy bodies. Neurosci Lett 2007;415:219-24. (Pubitemid 46400260)
32. Brooks D, Halliday GM. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull 2009;78:97-104.
33. Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res 2011;221:564-73.
34. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-58.
35. Janzen J, van 't Ent D, Lemstra AW, et al. The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study. J Neurol 2012;259:147-54.
36. Baxter MG, Chiba AA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol 1999;9:178-83. (Pubitemid 29201789)
37. Klinkenberg I, Sambeth A, Blokland A. Acetylcholine and attention. Behav Brain Res 2011;221:430-42.
38. Bohnen NI, Kaufer DI, Hendrickson R, et al. Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol 2006;253:242-7. (Pubitemid 43255898)
39. Ramirez-Ruiz B, Junque C, Marti MJ, et al. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement Geriatr Cogn Disord 2007;23:281-8. (Pubitemid 46631933)
40. Kostić VS, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010;75:857-63.